DL
REGN icon

DOHJ LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

DOHJ LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,208
Closed -$710K – 107
2025
Q2 		$710K Buy
1,208
+619
+105% +$345K 0.21% 93
2025
Q1 		$373K Buy
589
+77
+15% +$53K 0.09% 124
2024
Q4 		$365K Buy
+512
New +$430K 0.08% 127

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DOHJ LLC's REGN Position: Q3 2025 in Review

DOHJ LLC sold out of Regeneron Pharmaceuticals (REGN) in Q3 2025, closing a stake of 1,208 shares — an estimated $710K sold.

DOHJ LLC first reported a position in REGN in Q4 2024 and held it in 3 quarters. The position peaked at $710K in Q2 2025. 1,245 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

  • DOHJ LLC reported no remaining Regeneron Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • DOHJ LLC sold 1,208 Regeneron Pharmaceuticals shares in Q3 2025, an estimated $710K.
  • DOHJ LLC first reported a position in Regeneron Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • DOHJ LLC's Regeneron Pharmaceuticals position peaked at $710K in Q2 2025.
  • 1,245 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on DOHJ LLC's 13F filing for Q3 2025.